Type One Energy Moving to Tennessee
Type One Energy announced today it is relocating to Clinton, Tenn., to build Infinity One, the company’s stellarator fusion prototype machine. According to a release, the project will be called…
Type One Energy announced today it is relocating to Clinton, Tenn., to build Infinity One, the company’s stellarator fusion prototype machine. According to a release, the project will be called…
Cellectar Biosciences enrolled its first patient in its Phase 1b clinical trial evaluating iopofosine I 131 in pediatric patients with relapsed or refractory malignant high-grade gliomas (pHGG), the company announced…
Elephas has closed a $55 million Series C funding round led by Venture Investors Health Fund and State of Wisconsin Investment Board (SWIB), the company announced today. “We remain intensely…
Cellular Logistics and Allele Biotech, a company that explores the mechanisms of biological processes to develop technologies and products for biomedical researchers, have partnered, the company announced recently. The two…
Cellectar Biosciences has partnered with Meaningful Insights-BioTech Analytics (MiBA), a data subsidiary of American Oncology Network (AON), the organization announced today. According to a release, the partnership will look to…
Nimble Therapeutics and Genentech, a member of the Roche Group, have expanded their partnership, the company announced today. According to a release, the companies executed a license agreement for the…
NorthStar Medical Radioisotopes has expanded its strategic collaboration with Curadh, the organization announced today. According to a release, under the new agreement, NorthStar will manufacture and distribute patient doses for…
Cellectar Biosciences has expanded its licensing agreement with the Wisconsin Alumni Research Foundation (WARF) for intellectual property that was the result of collaborative research conducted at the University of Wisconsin…
Exact Sciences has awarded $1.3 million to 23 organizations through its Funding Opportunities for Colorectal Screening Uptake Strategies (FOCUS) Program, the company announced today. According to a release, the FOCUS…
SHINE Technologies and Nucleus RadioPharma are partnering to advance radioligand cancer treatments, SHINE announced recently. “We are proud to partner with Nucleus RadioPharma to supply the high-purity lutetium-177 that powers…